Ausgabe 1/2005
Inhalt (18 Artikel)
Methodological considerations in the design of trials for safety assessment of new drugs and chemical entities
Cornel Pater
Presence of factors that activate platelet aggregation in mitral stenotic patients' plasma
Istemihan Tengiz, Ertugrul Ercan, Fahri Sahin, Emin Alioglu, Can Duman, Guray Saydam, Filiz Buyukkececi
Carotid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors
Mark A Espeland, Daniel H O'Leary, James G Terry, Timothy Morgan, Greg Evans, Harald Mudra
Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]
Petr Ostadal, David Alan, Petr Hajek, Jiri Vejvoda, Martin Mates, Peter Blasko, Josef Veselka, Milan Kvapil, Jiri Kettner, Martin Wiendl, Ondrej Aschermann, Josef Slaby, Eduard Nemecek, Frantisek Holm, Marek Rac, Milan Macek, Jana Cepova
The Blood Pressure "Uncertainty Range" – a pragmatic approach to overcome current diagnostic uncertainties (II)
Cornel Pater
Symptomatic relief precedes improvement of myocardial blood flow in patients under spinal cord stimulation
Holger Diedrichs, Carsten Zobel, Peter Theissen, Michael Weber, Athanassios Koulousakis, Harald Schicha, Robert HG Schwinger
Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients – the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]
E Lars Penne, Peter J Blankestijn, Michiel L Bots, Marinus A van den Dorpel, Muriel P Grooteman, Menso J Nubé, Ingeborg van der Tweel, Piet M ter Wee
Effect of rosuvastatin on outcomes in chronic haemodialysis patients – design and rationale of the AURORA study
Bengt Fellström, Faiez Zannad, Roland Schmieder, Hallvard Holdaas, Alan Jardine, Helen Rose, Wim Wilpshaar
Exercise training improves aerobic endurance and musculoskeletal fitness in female cardiac transplant recipients
Mark Haykowsky, Kenneth Riess, Linda Figgures, Daniel Kim, Darren Warburton, Lee Jones, Wayne Tymchak
The SPHERE Study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses. [ISRCTN24081411]
Andrew W Murphy, Margaret E Cupples, Susan M Smith, Molly Byrne, Claire Leathem, Mary C Byrne
Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction
Aslan T Turer, Kenneth W Mahaffey, Dianne Gallup, W Douglas Weaver, Robert H Christenson, Nathan R Every, E Magnus Ohman
Coronary artery bypass surgery in high-risk patients
Alper Sami Kunt, Osman Tansel Darcın, Mehmet Halit Andac
Predictors of post-operative mortality following treatment for non-ruptured abdominal aortic aneurysm
Sigitas Urbonavicius, Henrik Vorum, Grazina Urbonaviciene, Mindaugas Trumpickas, Dainius Pavalkis, Bent Honoré
The clopidogrel after surgery for coronary artery disease (CASCADE) randomized controlled trial: clopidogrel and aspirin versus aspirin alone after coronary bypass surgery [NCT00228423]
Alexander Kulik, Michel Le May, George A Wells, Thierry G Mesana, Marc Ruel
Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy? – A systematic review
Madlaina Scharplatz, Milo A Puhan, Johann Steurer, Annalisa Perna, Lucas M Bachmann
Compliance of a cobalt chromium coronary stent alloy – the COVIS trial
Jens Hagemeister, Frank M Baer, Robert HG Schwinger, Hans W Höpp
Combining short stent implantation and drug-eluting stenting for routine use yields a low restenosis rate
Ulrich Dietz, Cheryl Dauer, Heinz Lambertz